Varun Nanda recently became President of Sumbhav Consulting, a company offering strategic plans and advice for health care, biotechnology, pharmaceutical, and diagnostic businesses. Originally studying mechanical engineering at the Delhi College of Engineering, Nanda relocated to the United States after receiving his Bachelor’s degree and spending two years at Hindustan Motors, Ltd.’s Heavy Engineering Division. At Eastern Illinois University, he earned his Master of Business Administration, and then enrolled in The University of Texas at Austin’s Ph.D. program, majoring in management. In 1989, Varun Nanda became the Assistant Product Manager at CompuDrug USA, Inc., in Austin, developing a university program and marketing research systems to pharmaceutical companies.
Moving northeast to Piscataway Township, New Jersey, Varun Nanda became the Product Manager at Enzon Pharmaceuticals, Inc., where he helped the revenue grow more than 100% for 3 consecutive years. This aggressively rapid growth brought Enzon to the 56th rank on Inc. Magazine’s list of the 100 fastest-growing small public companies in 1993. Varun Nanda then joined pharmaceutical giant Novo Nordisk A/S, where he established strategies and plans for the company’s insulin delivery systems, hemophilia drugs, growth hormones, and a half-dozen hormone replacement therapy products.
Crossing the United States, Varun Nanda found himself at Genentech, Inc., in San Francisco, California, serving as Vice President for the Avastin brand’s Sales and Marketing department, then earning his way into the role of Senior Vice President and Global Head of Oncology. In Seattle, Nanda signed on as the Senior Vice President of Global Commercial Operations for Dendreon Corporation, launching the prostate cancer treatment Provenge in the United States and preparing for its debut in Europe.
With this wide portfolio of positions at varying companies, Varun Nanda puts his experience to work for others seeking his help at Sumbhav Consulting, where he can independently produce similarly impressive results for companies looking to launch new products or get past their initial startup phase.
